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Abstract

Introduction

Despite nearly a half-century of study, the clinical
value of spontaneous crystalluria (Cx) examinations in
calcium stone formers (CaSF) is still uncertain. The analytical complexity of urine particle study is largely responsible for this situation. As a result, there is no consensus regarding technical methods in Cx with several
techniques for urine sampling and three different instruments currently used for particle study, namely, particle
counting (PC), light microscopy (LM) and petrographic
microscopy (PM). In this work, we first examined urine
sampling and instrument methods regarding their appropriateness for Cx studies. Then we performed a comparative analysis of Cx studies in CaSF. Despite many
technical and clinical discrepancies, several studies agree
that the frequency of "all particles" and of the weddellite
and whewellite calcium oxalate (CaOx) crystalline
phases are increased in CaSF as compared to normal
subjects (NS). Particle sizes and aggregation ratio are
also often increased. Altogether, these results reinforce
the need for an efficient method for Cx studies in these
patients. Examining each technique leads us to conclude
that most particle parameters can be studied by "direct
LM" observation of freshly voided urine samples, i.e.,
urine samples without any separation steps. For clinical
applications, several examinations should be performed,
first to define the specific Cx characteristics in a patient,
then for the study of treatment efficiency on Cx control,
and finally, during the patient follow-up. Due to Cx
variability in each patient, the frequency of Cx examinations during each phase needs to be determined in longterm comparative prospective studies of CaSF.

The annual incidence of calcium oxalate urolithiasis
in western societies ranges between 7 and 21 per 10,000
(Smith, 1989). Consequently, medical and socio-economic consequences of urolithiasis call for new strategies for its prevention (Consensus conference, 1988).
Among these strategies, the finding of crystalline particles 1 in urine of calcium stone formers (CaSF) long ago
raised strong hopes for the potential usefulness of crystalluria (Cx) examinations in these patients: From "the
most ancient times there was a persuasive belief that Cx
and stone formation are somehow related" (Hallson,
1988). It was, therefore, expected that Cx studies could
give information about the calcium lithiasis processes at
work in CaSF: "Since the crystals observed in urine
have grown in the urinary tract, they should be subject
to at least some of the same factors involved in urolithiasis" (Wemess et al., 1981). Finally, hopes that Cx
studies could be of diagnostic value, in particular for the
prediction of stone recurrence and for patient follow-up,
were the greatest incentives of almost one-half century
of Cx research in CaSF (Black, 1945). Nevertheless,
the interest of Cx studies in these patients is still not
firmly established. Most disturbing from the beginning
of these studies were the observations that Cx episodes
could be observed both in CaSF and in healthy subjects
in whom no renal stone disease had been recognized
(Cottet and Vittu, 1952; Robertson, 1969; Robertson et
al., 1969), showing that there is no "one-to-one" correspondence between Cx and stone formation processes
(Wemess et al., 1981). The main difficulties encountered during Cx studies, however, are a series of technical
and instrumental problems related to both urine sampling
and processing, and to the instruments used for particle
studies. In this paper, we analyzed these difficulties, the
methods developed to solve them, and the results of Cx
examinations in CaSF. We finally suggest that "direct
light microscopy (LM)" study of urine samples is a simple, reliable and efficient method for Cx studies.

Key Words: Calcium stone formers, crystalluria, urine
sampling, particles counting, petrography, light microscopy, patient follow-up.
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term "particle(s)" is used to cover both crystals and
aggregates when a distinction is not relevant.
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Figure 1 (a-hon the facing page 217; i-p on page 218). Light microscopic illustrations of calcium oxalate crystals,
crystal aggregates and associations most frequently found in urine of CaSF. From top to bottom and clockwise. la.
Whewellite in oval crystals with swollen extremities ("dumb-bell"). lb. Whewellite in pseudohexagonal habit dispersed
among a background of granulations made of amorphous complex urates (polarized light). le. Whewellite aggregates
of pseudohexagonal crystals with granulations of amorphous complex urates. ld. Whewellite in "lenticular" or "hematiform" habit associated with brushite aggregates (arrow) and amorphous carbonated calcium phosphates (ACCP) granulations. le. Whewellite in sticks with straight or slightly swollen sides in a background of amorphous complex urates
(polarized light). lf. Whewellite in hexagonal crystals with a stretched appearance encountered during ethylene glycol
intoxication (polarized light). lg. Weddellite in bipyramid crystals ("envelope"). lb. Weddellite bipyramid crystals
in aggregates with 2 macles. Bars = 16 µm (for la to lf, and lh) and 65 µm (for lg).

numbers of crystals and be composed of one or several
crystalline phases.

Particle parameters
Cx studies primarily involve the qualitative and
quantitative study of urinary particles using a range of
appropriate parameters. These parameters are briefly
examined below.

Particle morphology: Isolated urinary crystals and
aggregates are frequently identified using either LM
(Baumann, 1978; Coe et al., 1992; Elliot et al., 1976;
Osborne et al., 1986) or scanning electron microscopy
(SEM) (Berg et al., 1976; Edyvane et al., 1987; Khan
and Hackett, 1986; Rodgers et al., 1988; Werness et
al., 1981). However, in clinical practice, urinary particles are mostly found in various associations such as
whewellite and weddellite, weddellite and uric acid,
weddellite and brushite, and amorphous calcium phosphate, etc., which are rarely illustrated (Daudon, 1989,
1993; Valyasevi and Dhanamitta, 1974). Other qualitative observations which may be of interest for Cx interpretation concern the presence of heterogeneous nucleation processes observed on epithelial linings, cell debris,
urinary casts, etc. (Coe et al., 1992). The main particle
habits, their associations and some frequently encountered nucleations in urine of CaSF are illustrated in Figures
1 and 2.

Particle qualitative parameters
Crystalline phases: In aqueous solutions supersaturated with CaOx, crystals corresponding to the three hydrated CaOx salts are observed. In urine, which is normally supersaturated with all three hydrates (Gardner,
1975), crystalline particles corresponding to monohydrate salt, or whewellite, and to dihydrate salt, or weddellite, are observed. CaOx trihydrate, the least stable
and most soluble phase, which may occur transiently at
the time of initial precipitation (Tomazic and Nancollas,
1979), is found in urine in rare situations such as after
certain drug treatments (Daudon et al., 1987b). In addition to the CaOx crystalline phases, several others, including uric acid and urate salts, calcium phosphates and
struvite, are observed in urine of CaSF.
Crystalline phase habits: In vivo, as in chemical
solutions, each crystalline phase can be present under
several habits since growth conditions are not necessarily
the same for all sides of the crystal (Nancollas, 1979,
1983). The presence of particles with the same crystalline molecular phase but with different habits can
lead, if unknown, to the risk of Cx misinterpretations
(Osborne et al., 1986). In a few cases, specific crystal
habits have been related to particular situations such as
the dodecahedral habit of weddellite crystals observed in
highly hypercalciuric urine samples in place of the common octahedral habit (Daudon, 1987a) and the whewellite habit observed after ethylene glycol poisoning with
a habit strikingly different from the usual oval or dumbbell habits (Godolphin et al., 1980; Miller, 1990;
Terlinsky et al., 1980, 1981).

Particle quantitative parameters
Sizing: Particles in urine are present in a wide
range of sizes and are not easily measurable (see Figs.
1 and 2). To obtain a representation of the particle sizes
in a urine sample, several indicators such as the mean
particle size, the maximal particle size, and the sizenumber distribution spectrum are used.
Abundancy: Cx abundancy can be quantified using
the particle number and volume.
Aggregation ratio
An aggregation ratio is computed as the number of
aggregates divided by the total number of particles in a
sample.

Particle frequency

Aggregates: Due to physico-chemical interactions,
crystals can join together in polycrystalline structures or
"aggregates". These formations can include various

Particle frequency relates to the mere presence or
absence of particle(s) in a urine sample. Theoretically,
216
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Figure 1 (legend continued from page 216). From top to bottom and clockwise. li. Weddellite in truncated pyramids with a rectangular-deformed base. lj. Weddellite in dodecahedral faces giving an hexagonal appearance usually
associated with hypercalciuria (Ca > 6 mmol/l) (polarized light). lk. Weddellite crystal in square habit with two
opposite triangles at the inside (polarized light). ll. Large weddellite aggregate composed of about 50 crystals. lm.
Trihydrated calcium oxalate asymmetric hexagonal habit in thin lamella. ln. Trihydrated calcium oxalate in thick plate
("race course"). lo. Mixed crystalluria of whewellite crystals in "dumb-bell" and octahedral weddellite crystals in a
voluminous aggregate (polarized light). lp. Whewellite (oval) and weddellite (envelope) in a voluminous heterogeneous
aggregate (polarized light). Bars = 16 µm (for li to ln, and lp) and 65 µm (for lo).

Table 1. Crystalluria study. Main crystal qualitative and quantitative variables and associated urine biochemical and
physico-chemical variables.
Crystal qualitative
variables

Crystal quantitative
variables

Urine biochemical
variables

Urine physico-chemical
variables

crystal species

size; volume; number

calcium; oxalate

pH; density; ionic strength

crystal habits

aggregates number

phosphate; urate

conductivity

heterogeneous nucleation
phenomena

aggregation ratio

citrate; sulfate; sodium;
potassium; magnesium;
pyrophosphate; urea; creatinine

supersaturation

associated cells; cell debris
bacteria; casts

frequency

macromolecular inhibitors

crystallization
inhibition power

the observation of a single particle is sufficient to qualify
an urine sample as "Cx positive". It has long been
known that, even in recurrent CaSF, urine samples are
not always "Cx positive" (Cottet and Vittu, 1952;
Robertson et al., 1969). Conversely, urine samples
from normal subjects (NS), i.e., people without any
known stone and/or renal disease, are not always "Cx
neg,:tive", i.e., free of particles. These observations can
be quantified using the frequency parameter, i.e., the
number of "Cx positive" samples over the total number
of samples in a series. Frequency can be studied for the
presence of particles in urine whatever the chemical
composition giving an "all particles" frequency. Frequency can also be studied separately for each crystalline
phase, for example, for the weddellite phase, the brushite phase, etc., as well as for association, such as urate
and weddellite phases.

Robertson et al., 1981). The main Cx particles and
urine associated variables are grouped in Table 1.

Instruments for Particle Studies
The instruments used for clinical application of Cx
belong to three different families: light microscopy
(LM), petrographic microscopy (PM) and particle counting (PC). For each instrument, its principle, the sample
preparation method, and the particle parameters which
can be studied are discussed below. The heading Feasibility covers the skills required by operators, time per
sample, and the associated costs.

Light microscopy (LM)

Other crystalluria parameters

Principle: Observation is made by optical light
transmission. To improve differentiation between crystal
habits, polarized light observation was introduced for
particle identification (Dyer and Nordin, 1967).

To fully describe a urine sample regarding its crystallization status, study of urine particles is necessary but
not sufficient. Other urine variables must be used, in
particular, the biochemical variables as well as physicochemical variables such as supersaturation (Robertson et
al., 1976a, 1981; Tiselius, 1991; Werness et al., 1985)
which, in the final analysis, are responsible for crystallization. All these variables are of great help for the
final step of Cx interpretation (Daudon, 1987b, 1993;

Sample preparation: In most LM studies, "indirect LM" is performed on a 10-20 µl aliquot of the sediment obtained after isolation of the particles by filtration
or centrifugation of a 1-2 ml aliquot of the urine sample.
"Indirect LM" on sieved fractions of urine were also
used in the past (von Sengbusch and Timmermann,
1957a,b, 1958). In ourlaboratory, we developed "direct
LM" studies of urinary samples. In this method, the
particles are studied as voided using a 20 µl aliquot of
219
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Figure 2. Mixed crystalluria in CaSF. From top to bottom and clockwise. 2a. Whewellite (oval) crystals associated
with complex amorphous urates in granulations (polarized light); 2b. Heterogeneous crystalluria with whewellite, weddellite (macle) and dihydrated uric acid (arrows) (polarized light). 2c. Heterogeneous nucleation of octahedral weddellite crystals (arrows) on anhydrous uric acid (polarized light). 2d. Heterogeneous nucleation of whewellite in stick
crystals on anhydrous uric acid crystals (polarized light). 2e. Heterogeneous nucleation ofbrushite (arrows) on dodecahedral weddellite with amorphous calcium phosphates in granulations. 2f. Heterogeneous nucleation of brushite over
weddellite and, conversely, of weddellite over brushite. 2g and 2h. Heterogenous crystalluria with whewellite, struvite
and granulations of amorphous calcium phosphate (2g), and with weddellite, struvite and granulations of amorphous
calcium phosphate (2h). Bars = 30 µm (for 2a, 2b, 2d, 2g, and 2h); 65 µm (for 2c and 2e); and 16 µm (for 2f).

a well-homogenized urine placed in a Mallassez cell as
for cytological studies (Daudon, 1987a, 1989; Daudon
et al., 1983, 1987a; Nguyen et al., 1987).

be studied. The characteristic refractive indices are
associated with a given crystalline phase.

Particle study: Qualitative parameters: Using
LM, all particle qualitative descriptors can be studied:
crystalline phases and habits, aggregates, etc.

Particle number: Following the work of
Wemess et al. (1981) semi-quantitative results are obtained using a scale based on the observed number of
crystals per filter from a 2 ml sample. A scale is used
to attribute a score for quantifying the particles collected
on the filters: 0 crystals (i.e., "negative" crystalluria)
= O; 1-200 = 1+; 200-500 = 2+; > 500 = 3+.
Summing the scores from the individual voidings and dividing the obtained value by the number of voidings during the 24-hour collection period provides the "crystalluria score".

Particle study: Quantitative variables:

Particle study: Quantitative parameters:
Sizing: Sizes of particles are studied using a
graduated eye-piece ocular and are limited only by the
resolution limit of LM, i.e., 1 µm.
Particle abundancy: The total particle number
and concentration are measured by taking into account
the urine sample and cell chamber volumes. Particle
volume is not usually measured by LM although an approximation can be obtained in certain cases (see
Discussion).

Particle sizes:
These parameters are not
usually studied in Cx studies with PM.
Feasibility: PM requires full isolation of the
particles involving lengthy preparation steps. PM observation is a relatively sophisticated method and requires
expert technicians. The costs of PM instruments are
similar to those for LM.

Aggregation: Composition and number of aggregates can be recorded. From the total particle number and the aggregate number, the aggregation ratio can
be computed.
Feasibility: A well-trained technician is able to
reliably and rapidly recognize most crystalline phases in
their various habits. An extensive qualitative and quantitative "direct LM" Cx study is performed by an experienced observer in about 15-20 minutes. This time must
be at least be doubled when using "indirect LM", due to
the required technical handling of the sample. A goodquality polarized light microscope with several magnification lenses costs about $12,000; when equipped for
microphotography and video imaging, the cost totals
about $20,000.

Particle counting (PC)
Principle: The principle of these instruments is
based on a modification of an electric parameter triggered by particles coming across the detector chamber.
Sample preparation: Use of PC in Cx studies was
introduced by Robertson (1969). A prefiltration step of
the samples is needed to eliminate particles with sizes
greater than 74 µm which would plug the inlet of the instrument. Furthermore, the particles have to be put in
suspension in an electrolyte. Since every particle which
passes across the measuring cell will be recorded irrespective of its nature, a technique for special handling of
sample has been developed for counting the CaOx particles only. Two samples are run in parallel: one is
ethylenediaminetetraacetic acid (EDT A) treated to dissolve the calcium oxalate and phosphate crystals; its
companion sample is similarly treated except that the
EDT A is replaced with a saline solution. The difference
between the two counts is taken as the neat calcium

Petrography microscopy (PM)
Principle: PM performs crystalline phase determination by comparing the refraction index of the particles
with the known refraction indices of organic oils.
Sample preparation: PM requires full isolation of
the particles using several filtration and drying steps.
Particle study: Qualitative variables: With PM,
the crystalline chemical phases of the main particle can
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oxalate crystal number.

with diet (Cottet and Vittu, 1952), beverages consumed,
drinking habits (Black, 1945), and volume of liquid intake (Black, 1945; Berlyne et al., 1976). The post-prandial alkaline tide may favor formation of calcium phosphate nuclei on which calcium oxalate can crystallize
(Schwille, 1985). Many other variables, such as, seasons (Hallson and Rose, 1977), physical activity (Irvine
et al., 1986; Rodgers et al., 1988, 1991), and ethnic
group (Rodgers et al., 1992; Valyasevi and Dhanamitta,
1974) can influence Cx. Another source of Cx variability is urine instability with particles in equilibrium with
a supersaturated liquid phase. As soon as the urine is
voided, any change in temperature and composition
could easily alter this equilibrium with risks for the native particles to be modified qualitatively and quantitatively. Thus, in order to perform reliable comparisons
between Cx data, a sampling protocol able to control
both for patient variability and urine instability has to be
chosen.

Particle parameters: Qualitative variables: No
direct information regarding the particle can be obtained
using PC.
Particle study: Quantitative variables:
Particle sizing: Particles above 3.8 µm were
recorded by Robertson (1969), although a smaller size
(2.5 µm) has also been recently observed (Rodgers et
al., 1991).
Particle quantitation: A size-number distribution spectrum is recorded over the range 3.8-48.6 µm.
Standardization of the apparatus permits derivation of a
volume-size distribution spectrum. Then, a crystal
volume per unit volume of urine or "volume-concentration" is computed.
Feasibility: PC are easy to use and can be
equipped with a data treatment facility. Although the
instrumental counting step is rapid, sample manipulations
require a long time. Cost of instruments is from about
$15,000 to 30,000 depending on automation and computing facilities.

Urine sampling
In order to control for patient variability, most
primary studies were performed with strict control of
patient conditions (Robertson et al., 1969). Patient
preparations with regimen loaded in oxalate, calcium and
carbohydrates were also used while allowing metabolic
lithiasic dysfunction to be revealed by inducing or increasing Cx in these subjects (Cottet and Vittu, 1952,
1953; Robertson and Peacock, 1972; von Sengbusch and
Timmermann, 1958). In more recent studies, first urine
of the morning, which is more concentrated due to night
water restriction, is favored (Daudon and Reveillaud,
1984; Daudon et al., 1983, 1987a; Hermann and
Schwille, 1992; Sriboonlue et al., 1990).

Other instruments for particle studies
Physical methods must be used for the study of
crystals less than 1 µm as for most calcium phosphate
crystals (Tozuka et al., 1987). Definite identification of
the major habits of urinary CaOx crystals has also been
made using crystallographic analysis (Catalina and
Cifuentes, 1970a,b). These methods are also used for
unusual crystal habits, e.g., thin needles seen in urine
after ethylene glycol poisoning which were first assumed
to be hippurate crystals but were later identified, thanks
to X-ray diffraction, as whewellite crystals (Godolphin
et al., 1980). SEM, with its large depth of focus,
shows the morphological features of crystals and has
been used for illustrating CaOx crystals in urine in many
studies. X-ray diffraction crystallography, and SEM
alone or coupled with an energy dispersive X-ray microanalysis systems, are also sometimes used in clinical
studies. In our laboratory, we showed that infrared
spectrophotometry alone or coupled to an infrared
microscope for individual crystals with sizes above 8 µm
allows rapid identification of molecular phases (Daudon
et al., 1991). Chemical methods have also been devised
for calcium oxalate and phosphate crystal determination
in urine (Hallson and Rose, 1988).

Urine storage

In the context of clinical studies, a storage period
between patient voiding and examination is generally unavoidable. There is no consensus as to the duration and
temperature which would entail no significant modification of the spontaneous Cx properties. In many studies,
great care is taken to avoid any temperature variations
from the time of voiding to the time of examination, by
collecting urine at 37°C and conducting all the technical
processes and instrument examination at this temperature. These conditions are not easy to comply with in
routine clinical practice and several laboratories questioned the stringency of these conditions. Several authors estimated that urine samples stored for up to 2
hours showed no significant change in urine composition
or bacterial effects on crystallization (Hallson and Rose,
1977). Recording samples pH just after voiding, and
then at the time of study, allows one to record any
changes due to bacteria (Daudon et al., 1983). In these
conditions, no changes in mean particle sizes of samples

Urine Sampling and Processing
Urine biochemical composition and saturation, i.e.,
the crystallization "driving forces", are highly variable
(Finch et al., 1981; Robertson and Peacock, 1984;
Robertson et al., 1972, 1976a). As a result, Cx varies
222
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Table 2. Frequency of "all particles" and CaOx particles in CaSF and NS.
Reference

Method

Number of
subjects
CaSF/NS

Frequency %
"all particle"
CaSF/NS

Frequency%
CaOx phases 1
CaSF/NS

Cottet and Vittu (1952)

"indirect LM"

74/24

78.4/16.7

60/-

Hallson and Rose (1976)

"indirect LM"

121/54

48/22

16/11

Baumann et al. (1984)

"indirect LM"

12/16

Sriboonlue et al. (1990)

"indirect LM"

29/36

68/43

Wemess et al. (1981)

PM

89/16

100/1002

Caudarella et al. (1986)

PM

86/40

K.lepikov et al. (1991)

"indirect LM"

372/-

Chevalier et al. (unpublished)
1

Wbewhellite and/or weddellite;

"direct LM"
2

75/12
45/18
78/19.8
25.8/12.2

44/17

328/123

66.8/22

52/22 3

3

3p

sediment from 2 ml of urine aliquot;

< 0.001

------------------------------------------------------------------------Table 3. Frequency(%) of the accompanying phases in urine of CaSF.

Reference

Method

Urate and
uric acid

Calcium phosphate (brushite,
carbapatite, and/or struvite)

16.8

18.5

Cottet and Vittu (1953)

"indirect LM"

Hallson and Rose (1976)

"indirect LM"

Wemess et al. (1981)

PM

11

100

Caudarella et al. (1986)

PM

5

10

Klepikov et al. (1991)

"indirect LM"

3.6

1.2

Chevalier et al. (unpublished)

"direct LM"

8.9

39.1

33

Table 4. Maximum sizes of CaOx single crystals and aggregates (in µm) observed in urine of CaSF and NS.

1

p

Reference

Method

Single crystals
CaSF/NS

Aggregates
CaSF/NS

von Sengbusch and Timmermann (1958)

"indirect LM"

60/-

700/-

Dhanamitta et al. (1970); Valyasavi et al. (1973)
Hallson and Rose (1976)
Buli et al. (1982)
Baumann (1978); Baumann et al. (1984)
K.lepikov et al. (1991)
Daudon et al. (unpublished)

"indirect LM"
"indirect LM"
"indirect LM"
"indirect LM"
"indirect LM"
"direct LM"

< 0.05; 2p < 0.02
223
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Table 5. Particle aggregation ratio in CaSF and NS as
observed by LM studies.

Reference

Aggregation ratio
CaSF/NS (%)

Sriboonlue et al. (1990)
Hallson and Rose (1976)
Baumann et al. (1984)
Daudon (1989)

40/22
8/2
75/12
12/8

studying the particles sieved from urine samples on filters with several mesh sizes. (von Sengbusch and Timmermann, 1957a,b, 1958). It was shown that intake of
food-stuffs with a high oxalate content causes increased
excretion of "microstones", i.e., large crystalline aggregates with sizes up to 200-700 µm in conjunction with
single crystals.
In studies performed in Thailand
(Dhanamitta et al., 1967, 1970; Valyasavi and Dhanamitta, 1974, Valyasavi et al., 1967, 1973) where children living in rural areas suffer from bladder lithiasis,
CaOx crystals were "commonly found" in urine. A dietary survey showed that children in villages were eating
local vegetables rich in oxalate, contrary to children in
urban areas. Results of studies performed between children eating oxalate-rich vegetables versus control children fed with mother's milk, water and rice showed that
numerous medium (10-20 µm) and large (25-80 µm)
crystals as well as numerous aggregates up to 500 µm
were observed with a much higher frequency in the children eating oxalate-rich foods. In Great Britain, Hallson
and Rose (1976) observed an "all crystals" Cx frequency
of 48 % in CaSF versus 22 % in NS. Aggregation of
CaOx crystals occurred in 8 % of urine samples from untreated stone formers compared to 2 % for urine samples
of NS. Hallson and Rose (1976) also performed quantitative Cx studies using PC (see below). Later, Hallson
and Rose (1978) introduced an evaporation method for
studying urine crystallization properties. In Germany,
microphotographs of urine sediments were taken after
giving an oxalate oral dose to 18 recurrent active CaSF
and 16 NS (Baumann, 1978). It was shown that 9 patients formed aggregates with diameters above 50 µm in
the urine against only 1 subject in the NS group. More
recently, Baumann et al. (1984) studied 12 idiopathic recurrent CaSF and 16 NS after oxalate ingestion. A 140
µm maximum size for weddellite crystals was observed
in CaSF against 30 µm for NS. Similarly, Cx frequency
was 25 % in NS against 80-90 % in CaSF after oxalate
ingestion. All groups responded to oxalate loading with
a considerable increase in whewellite particles.
All the preceding studies were performed using "indirect LM", i.e., on urine particles isolated after several
technical steps. In the last few years, "direct LM" studies of the urine particle were initiated in France by
Daudon and his co-workers (Daudon, 1993; Daudon and
Reveillaud, 1984; Daudon et al., 1983, 1987a,b, 1989;
Nguyen et al., 1987). Cx particle parameter studies
were performed using first urine samples of the morning
collected at room temperature and examined in the two
hours following voiding. These studies have been performed in a continuously growing patient data base currently composed of 328 CaSF and 123 NS. The main
results concern the frequency of the various crystalline
phases, sizes and aggregation ratios. The relationship

stored up to two hours at 22 and 37°C (Elliot and
Rabinowitz, 1980) or in sizes and aggregation ratios of
samples stored 3-4 hours at room temperature (Fazil
Marickar et al., 1988) were observed using LM. Using
PC, a shift towards lower volume-size distribution
curves was observed but only after urine storage for 3
hours at 27°C (Irvine et al., 1986). When the whole
urine sample was used without dilution and acid treatment, it was observed that the number of crystals
changed rapidly as a function of temperature and time
(Adamthwaite, 1983a,b). These variations were attributed to the numerous tiny calcium phosphates crystals
that are in suspension in urine (Ahlstrand et al., 1984).
Results of Cx Studies in CaSF

In this section, Cx studies in CaSF are classified by
instrument family. According to the authors' own conclusions, they are further divided into "Cx proponents"
and "Cx opponents" regarding interest of Cx in CaSF.
The main results from the "proponents" are grouped in
Tables 2-5.
LM studies
"Proponents": One of the first studies was performed on members of a military unit stationed in India
(Black, 1945). The author identified two types of CaOx
crystals, one with "octahedral or envelope" form and the
other with a "dumb-bell or biscuit" form. These crystals
were later recognized as the main habits of weddellite
and whewellite, respectively. Black (1945) further noted
that Cx episodes were related to oxaluria, low water intake and "a lot of strong tea" consumption. He concluded that oxalate crystals can be passed in the urine
"for years without any tendency to calculus formation".
Cottet and Vittu (1952, 1953) performed, apparently for
the first time, comparative Cx studies between CaSF and
NS after a dinner with water restriction. These studies
gave the first quantitative evaluation of Cx frequencies
both in CaSF and NS for "all particles", CaOx and accompanying phases (Table 2). First attempts to study
particle sizes and number using LM were performed by
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between whewellite and oxaluria was confirmed and the
respective role of calcium and oxalate urinary concentration on the control of CaOx phases were analyzed. It
was found that the voided CaOx molecular phases depend on the calcium/oxalate molar ratio with weddellite
and whewellite particles nearly exclusively present for
calcium/oxalate ratio values over 14 and under 5, respectively. On the contrary, CaOx Cx frequency is dependant on the urinary calcium oxalate molar concentration product (Daudon and Reveillaud, 1984; Daudon et
al., 1989). In a recent Russian study of 372 nephrolithiasis patients, Klepikov et al. (1991) found urinary crystals in 44 % of the patients against 17 % of "symptomless
subjects"; accordingly, they suggest consideration of Cx
"as a preclinical manifestation of urolithiasis".

The best documented PM study is by Wemess et al.
(1981) in which 2524 voidings were studied: 202 urine
samples from 16 NS, 686 samples from 47 primary
hyperparathyroidism patients, 182 samples from 12
primary hyperoxaluria and 1454 samples from 89 idiopathic CaSF. Crystal numbers voided during 3 consecutive 24-hour periods were quantified using a "semiquantitative score" as described in Particle number
under Petrographic microscopy section. It was shown
that all patients, and CaSF in particular, had significantly greater crystalluria scores than NS (p < 0.001).
CaOx molecular phases appear to be under the control
of oxaluria, and patients with primary hyperoxaluria had
100 % of voidings with major or only whewellite crystals. In idiopathic CaSF, weddellite was 45 % against
8 % whewellite. Surprisingly, whewellite was observed
in 18 % of NS but no wedddellite. Buli et al. (1982)
studied Cx parameters including crystal number, sizes,
and number of aggregates in 50 CaSF; these variables
increased significantly in CaSF as compared to NS.
More recently, Caudarella et al. (1986) studied 86 recurrent CaSF and 40 NS. It was observed that Cx was
composed of weddellite "most frequently" in CaSF,
whewellite being found less frequently (9 %) whereas
weddellite was "nearly exclusively" found in Cx of NS.

"Opponents": One of the most cited reports in the
field of Cx studies in CaSF is from Dyer and Nordin
(1967) who studied urine samples from 10 male hypercalciuric stone-formers; these urine sample were kept at
37°C "until crystals were observed". The only crystals
which were observed were calcium oxalate and "one
form of calcium phosphate". There were "no clear difference between stone-formers and controls" with regard
to the voided crystalline phases. Elliot and co-workers
(Elliot and Rabinowitz, 1976; Elliot et al., 1976) studied
122 hospital urine samples from patients with no evidence of past stone disease. They used light and polarized microscopy and studied crystal molecular phases,
habits and sizes. The two main weddellite habits, the
bipyramids and the dodecahedral forms and the whewellite habits, with oval and dumb-bell forms, were recognized. Particle sizes were shown to be from 2 to 22 µm
for whewellite and 2 to 40 µm for weddellite. In another study, Elliot and Rabinowitz (1980) studied crystals size by structure and habit in urine samples from 27
NS and 22 SF and found that "the mean crystal size did
not support the conclusion that SF excrete larger crystals
than normal subjects". They concluded that "there was
no correlation between crystalluria and severity and duration of disease". Winkens et al. (1988) studied the
urinary sediments from 148 SF and 144 NS and found
that CaOx was the "predominant" crystal phase but
found no difference between SF patients and NS for
particle frequencies, numbers or sizes; they concluded
that this examination is "without clinical value".

"Opponents": In recent studies (Hermann and
Schwille, 1992; Hermann et al., 1991), 78 male and 38
female idiopathic recurrent CaSF were studied. Unexpectedly, CaOx crystals were either never or "only sporadically" seen in patients with pure CaOx or mixed
CaOx-phosphate stones. Hermann and Schwille (1992)
concluded that "calcium oxalate crystalluria does not
qualify as a diagnostic aid".
PC studies
"Proponents": The use of PC for Cx studies was
launched in 1969 and the method has been extensively
applied (Robertson, 1969; Robertson and Peacock, 1972;
Robertson et al., 1969, 1971, 1974, 1976a,b). Idiopathic recurrent CaSF and NS in the same conditions of diet
and fluid intake were studied. A higher "volume-concentration" of crystals (mm3 crystal/ml urine) was noted
in CaSF. This increase was attributed to a greater average crystal size in CaSF and not to the particle number.
Crystals excreted by controls were small (3-4 µm in diameter) with little or no aggregates, whereas, recurrent
SF passed, in addition to small crystals, larger crystals
(10-12 µm) as well as polycrystalline aggregates (from
20 to 300 µm). Robertson et al. (1972) refined the particle size-distribution relationship and showed that
"whereas the normal control excreted his calcium oxalate
as a unimodal distribution of small particles, the stoneformer had in addition a second peak of much larger
particles". In addition to a peak centered around 7-8

PM studies
"Proponents": Smith and colleagues (Smith, 1976;
Van Den Berg et al., 1976) developed PM studies in lithiasic patients. In the first series, they studied 8
patients with primary hyperoxaluria and 14 matched normal subjects. The frequency of crystalluria was 91 % in
patients against 18 % in NS; the crystals were whewellite
with sizes up to 100 µ.m "with evidence of aggregation".
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µm, a second peak of much larger particles (20-40 µm

dellite is the most often observed phase in CaSF; 1t 1s
found 2 to 4 times more frequently than in NS (Table
2). Phosphate and urate particles are also observed in
CaSF contrary to NS (Table 3). Amongst the quantitative particle parameters, the most common results relate
to the particle size. Using PC, "proponents" agree that
CaSF voided particles are of larger sizes which can be
grouped in a peak for sizes greater than 12.2 µm. Using LM, particle sizes up to 300 µm or more are observed (Table 4). Another parameter of interest might
be an increased particle aggregate formation ratio (Table
5). In summary, most "proponents" of Cx studies in
CaSF agree that CaSF appear more likely than NS to
present Cx episodes; the crystalline phases are usually
not observed in NS. These particles are often of larger
sizes and are in an increased aggregation state. These
observations favor Cx examinations in these patients.
They also involve important practical consequences
regarding the methods, instruments, and protocols used
for Cx studies in CaSF.

in diameter) was found in CaSF. Using a dividing line
set at 12.2 µm, an oral load of oxalate given to a CaSF
resulted in the appearance of a dramatic second peak,
contrary to NS who showed no increase. Using LM, the
larger particles were identified as weddellite crystals and
were often found to occur in aggregates up to 200 µm in
diameter. The same authors studied the relation between
the percentage of large crystals and aggregates of calcium oxalate with sizes arbitrarily set as 12 µm with an
index taking into account both urine CaOx supersaturation and inhibitory activity. The study was performed
in 8 recurrent idiopathic CaSF and 8 NS. The results
show that the percentage of "large crystals" is positively
correlated with a "saturation-inhibition index" (Robertson et al., 1976a). Finally, a linear relationship was
found between the average percentage of large CaOx
crystals and aggregates excreted by CaSF patients and
the severity of the disease (Robertson et al., 1981).
Following these studies, a number of laboratories performed similar PC studies in CaSF. In Great Britain,
Hallson and Rose (1976) found: "agree in the main with
these findings although there were striking exceptions".
In the United States, studies conducted by Crassweller
et al. (1979) using Robertson's method (not cited) gave
essentially the same results with both the particle
volumes and sizes significantly higher in CaSF.
Recently, in a study of Cx in stone-forming runners, it
was reported that in stone formers, the volume-size
distribution curve is trinodal with 3 peaks occurring
respectively for particle diameters of 2.5, 9 and 25 µm,
contrary to NS who present only the first peak (Rodgers
etal., 1991).

Discussion
Cx studies are not performed in most urological
centers. This is largely due to technical difficulties
linked with this examination. A relevant Cx method
should be able to: 1) perform spontaneous Cx studies,
i.e., to comply with requirements to retain, as near as
possible, urinary particles in their state at voiding; 2)
allow a study of the largest range of qualitative and
quantitative particle parameters; and 3) be compatible
with routine clinical applications in terms of simplicity,
speed and associated costs. In this section, we attempt
to outline such a method for the two main technical steps
of Cx study, namely urine sampling and instrumental
analysis. We finally examine the requirements for Cx
protocols in CaSF.

"Opponents": Hartung and Leskovar (1976) studied an indefinite number of NS and CaSF using the
Coulter counter technique (Robertson, 1969). There
was no significant difference in crystal number and
crystal volume between SF and controls. In another
study, the poor reproducibility of the PC size-spectrum
results led the author to stress that this examination is
"of little use" (Baumann, 1978).

Which method for urine sampling, storage and
handling?
Urine sampling: Cx studies can be performed on
early morning as well as on random urine samples that
are easier to collect (Crassweller et al., 1979; Fazil
Marickar et al., 1988; Hallson and Rose, 1976). Nevertheless, due to the overnight water restriction period,
first urine samples of the morning are probably a better
indicator of the calculogenic property in CaSF and
should be favored as far as possible (Daudon, 1993).

Cx Studies in CaSF: What are the Common Results?
Despite many technical and clinical differences, a
number of studies agree that several Cx parameters appear significantly different between CaSF and NS. A
first series concern the particle phase composition and
their relative frequency. But, the most cited parameter
is the frequency of "all particles" always higher in CaSF
as compared to NS (Table 2). This parameter alone underlines the fact that CaSF are more prone to void crystalline particles than NS. When the relative frequencies
are studied as a function of the crystalline phases, wed-

Urine storage: Storage periods of less than two
hours at laboratory temperature give reliable results
while at the same time being more convenient for patients and for laboratory work. Nevertheless, due to
large temperature variations observed in some countries,
laboratory temperatures during summer may be pretty
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high and appropriate measures are required for storage
of the samples. As pH variations in infected samples
will modify Cx particle parameters, pH of the urines
must be recorded just after voiding and then at the time
of study (Daudon et al., 1983; Dyer and Nordin, 1967).

sentative evaluation of the particle size-distribution
spectrum, we define the particle "mean size" as the
mean of the largest dimensions of the particles belonging
to the same crystal phase measured in at least twenty
different optical fields (Daudon, 1987a).
Particle
concentration and number are computed by taking into
account the slide chamber volume. An estimate of the
particle volume can be computed for the main crystal
habits using an unit particle volume by assimilating the
particle to the nearest simple geometrical volume. This
method has been useful for the follow-up of patients in
whom large variations in the volume of the same voided
crystalline phase occurred (Jouvet et al., 1994).
Concerning sample preparation, most LM studies are
performed using "indirect LM" on sediments. "Indirect
LM" suffers from the same drawbacks as PC and PM
with regard to the risks for native particle properties, the
inaccuracy related to work on sediments, and the time
and costs associated with particle preparation. Thus,
among all methods used for Cx studies in CaSF, "direct
LM" appears the best suited in terms of simplicity and
efficiency for all steps of Cx examinations.

Urine handling: The less demanding the sample
preparation, the more possible it is to examine particles
in their native state. Although there has been no comparative study of the effects of filtration, centrifugation
or drying steps, these time-consuming and costly operations are likely to affect the particles. In addition, as
observed during the study of cells in urine sediments,
methods based on the study of sediments are likely to
give inaccurate results with poor repeatability (Gadeholt,
1964; Winkel et al., 1974).
Which instrument for particle study?
Particle counting (PC): PC does not allow the
study of particle qualitative parameters and is restricted
to the quantitative study of particles. Particle counters
are standardized using spherical beads whereas most urinary particles are far from being spherical (Figures 1
and 2). It has been argued that the particle size-distribution spectra obtained by PC do not put an equal emphasis on the counting of all particles regardless of their
sizes (Ryall and Marshall, 1978). Regarding particle
quantity deduced from the size-distribution number
transformed into volume, this can result in errors due to
the cubic-size relationship involved (Parsons, 1992;
Ryall and Marshall, 1978). When the number and the
size pf crystals in urine samples were measured by
"direct LM" and PC, large discrepancies were found
between the results of the two methods (Hennequin et
al., 1991). Finally, for particle identification, another
method such as LM (Hallson and Rose, 1976; Robertson
and Peacock, 1972; Robertson et al., 1974) or SEM
(Rodgers et al., 1991) must be used.

Which Cx protocol for Cx studies in CaSF?
Using various Cx protocols and techniques, it has
been shown that Cx can be reduced as a result of drug
and diet treatments (Buli et al., 1982; Caudarella et al.,
1986; Cottet and Vittu, 1953; Crassweller et al., 1979;
Daudon et al., 1987a; Hallson and Rose, 1976; Hallson
et al., 1976; Robertson et al., 1974, 1976b; Smith,
1976; Van Den Berg et al., 1976; Valyasevi et al.,
1967, 1973; Wemess et al., 1981). These studies were
conducted on the simple premise that "if an antistone
therapy stops crystalluria, it can be expected to retard
urolithiasis" (Wemess et al., 1981). Using multivariable
statistical studies, we showed that Cx is the first discriminant variable between CaSF and NS (Chevalier et al.,
in preparation). These results show that Cx is a primary
significant risk factor in the calcium stone disease and
the value of Cx studies and attempts for its control in
CaSF is well founded.
The question still remains: which Cx protocol must
be used in order to apply Cx for the follow-up of this
disease? Obviously, the study of a few samples over a
short time period is likely to give results without great
meanings in most patients for whom no etiologic factors
can be clearly identified (idiopathic CaSF) (Nordin,
1979). Cx protocols must be used which are able to
take into account the variability of Cx due both to biological as well as to technical factors (see Urine
Sampling and Processing above). Repeated Cx observations are needed in order to define a patient's "specific
Cx status", i.e., his Cx frequency, the compositions,
sizes, aggregation ratios of the voided particles, etc.

Petrographic microscopy (PM): PM does not allow crystal phase identification of all particles (Hermann
and Schwille, 1992; Hermann et al., 1991). Particle
size study is not performed and particle abundancy is
given using a "crystalluria score", "a gross quantitation
of the degree of crystalluria" (Wemess et al., 1981).
PM requires skilled observers not usually found in most
clinical centers.
Light microscopy (LM): LM is well suited for
particle frequency and particle qualitative studies such as
crystalline phases and crystal habit studies. Regarding
quantitative aspects, particle size measurements can be
performed on all particles except for those particles
whose sizes are less than 1 µm, i.e., below the instrument resolution limit. The largest particle sizes can be
recorded for each phase. In order to have a more repre-
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Br. Med. J. April, 590-592.
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Martorelli M (1982) Studia della cristalluria come
metodo di valutazione dell terapia medico-preventive
della calcolosi renale (Crystalluria studies as a method
for the follow-up of stone formers). Minerva Nephrol.
4, 137-150 (in Italian).
Catalina F, Cifuentes L (1970a) Calcium oxalate:
Crystallographic analysis in solid aggregates in urinary
sediments. Science 169, 183-184.
Catalina F, Cifuentes Delatte L (1970b) Estudio de
las cristalurias oxalocalcicas (Studies of calcium oxalate
crystalluria). Arch. Espag. Urol. 25, 147-164 (in
Spanish).
Caudarella R, Rizzoli E, Malavolta N, Severi B,
Vasi V, Biagini G (1986) Cristallurie: un probleme a
debattre (Crystalluria: a questionable problem). Acta
Urol. Belg. 54, 49-56 (in French).
Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. New Engl. J.
Med. 327, 1141-1152.
Consensus conference: Prevention and treatment of
kidney stones (1988). J. Am. Med. Assoc. 260, 977981.
Cottet J, Vittu Ch (1952) Valeur semiologique de
l'epreuve de cristallurie provoquee (Semiological value
of induced crystalluria). Presse Med. 60, 551-553 (in
French).
Cottet J, Vittu Ch (1953) Sediment et lithiase
urinaire (Urinary sediment and renal lithiasis). Presse
Med. 61, 703-704 (in French).
Crassweller PO, Brandes L, Katirtzoglou A,

But, how long and how often must Cx examinations be
performed in order to give results taking into account Cx
variability in a patient? Three periods can be distinguished when deciding to use Cx examinations in CaSF.
In the first period, Cx characteristicE" are determined and
the study is conducted in the absence of treatments as far
as possible. Next, Cx examinations are used to assess
the efficiency of a medical treatment, including diet and
drug treatment, in controlling Cx. After having successfully determined these conditions, Cx will be performed
during the patient follow-up. In order to answer the
question of the frequency of Cx examinations during
these periods, comparative and prospective studies are
needed. It can only be expected that during the followup period, the frequency of Cx examinations will be less
than in the first two periods in as much as no change in
the medical status and/or living habits of the patient are
expected. In any case, many Cx examinations are
needed, and the possibility of obtaining rapid and
reliable results using "direct LM" as suggested above is
of further interest.

Conclusions
As early as in the first study analyzed, it was noted
that crystals can be passed in urine "for years without
any tendency to calculus formation" (Black, 1945). Later studies have shown that Cx in CaSF is more frequent
and is composed of crystalline phases rarely observed in
NS which tend to form larger particles and aggregates.
Furthermore, a number of studies have shown that Cx
can be modified as a result of a medical treatment.
Thus, Cx examinations are strongly advisable in these
patients at all stages of the disease. Unfortunately,
largely due to technical problems, there is at present no
consensus for the follow-up of CaSF using Cx. Analysis
of each technique shows that "direct LM" is a simple
and efficient method. Use of this method in long term
comparative studies could be of value to further assess
interest of Cx examination based protocols, in particular,
for the prevention of stone recurrence in these patients.
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Discussion with Reviewers
R. Tawashi and M. Akbarieh: From your experience,
what is the most critical variable in writing a protocol
for Cx studies using LM?
Authors: There are several critical variables which
have to be fulfilled in order to perform reliable Cx
studies in CaSF. The first critical variable is to study
the urinary crystalline particles in a state as near as
possible to voided, i.e., to perform "spontaneous" Cx
studies. It should be noted that this requirement is
applicable irrespective of techniques and instrument
used. However, taking into account the numerous handling steps required by all other methods including
"indirect LM", only "direct LM", which does not require any urine preparation steps, "is able to fulfill, at
best, the conditions of "spontaneous" Cx studies.
Two other requirements are also independent of the
chosen Cx technique: the need to perform repetitive
"spontaneous" Cx studies and the need to select a set of
reference Cx parameters. Due to patient as well as
healthy subject variability, only repetitive studies can
define the qualitative and quantitative Cx parameters
with a statistical value: molecular phases voided and
their frequencies, particle sizes, aggregation ratio, etc.
Obtaining one or even a few Cx results in a patient is
likely to have, in most cases, only no more than an anecdotic value in particular for idiopathic calcium nephrolithiasis patients. The third critical variable is linked to
the need of having a reference set of Cx parameters.
One must choose between basing this reference set on a
strictly defined patient cohort or on the patient himself.
Due to the difficulty in controlling all parameters (age,
sex, calcium nephrolithiasis etiology, stage of the disease, regimen, diet, drugs, etc.), using the patient as his
or her own reference is often the most accurate and
practical way for using Cx studies in patient follow-up.
Only in the case of large comparative studies, can sever-
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al patient series be used. We take this opportunity to
stress that in most cases, statistical requirements are
such that the number of patients and urine samples required, combined with the long time associated with
most recurrent stone events, strongly appeal for cooperative studies between stone clinics on a national, or when
possible, an international basis.

R. Tawashi and M. Akbarieh: In your view, what
would be the role of crystal phase transition in Cx determination or the interpretation of results obtained, particularly when it comes to the storage and/or filtration of
urine?
Authors: As strongly advocated in our paper and repeated above, we think that clinically meaningful Cx
studies must be "spontaneous" Cx studies. Other Cx results need careful evaluation as to whether the results of
Cx changes are the consequences of particle preparation
steps such as filtration, storage, dilution, etc., or are
they the results of physicochemical steps such as cooling, pH adjustments, etc. Nevertheless, well-controlled
physicochemical treatments are easier to interpret than
the variations of Cx parameters due to the handling
steps. We have some experience on the modifications of
Cx parameters of urine samples after 48 to 72 hours
storage at 4 °C. We always perform these studies after
having first studied the urine samples immediately after
voiding, i.e., their "spontaneous" Cx parameters. Results of our studies (unpublished) can be summarized as
follows. The main interest of crystal phase transitions
observed after urine storage in the cold is the study of
the relationships between crystal phases and the biochemical composition of urine. Depending on the urine
supersaturation level, crystalline phase transitions will
occur more or less rapidly. For instance, when urine
pH is low, namely less than 5.2, uric acid dihydrate
crystals can form in urine despite low urate concentration (1-1.5 mmol/1). This crystal phase may be either
stable or able to transform into anhydrous uric acid
crystals depending on the supersaturation level. In
contrast, if urine pH is higher than 5.5, precipitates of
complex amorphous urates rather than uric acid dihydrate may occur in cases of high urate concentration ( >
4 mmol/1). In such conditions, the formation of uric
acid dihydrate crystals will occur progressively at the
expense of disappearing amorphous urates.
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